Endometriosis as a Chronic Disease - Impact on Patients Quality of Life

In: Quality in Sport · 2025 · vol. 46 , pp. 66673 · doi:10.12775/qs.2025.46.66673 · W4416422171
article OA: diamond CC0

Abstract

Endometriosis is a chronic gynecological condition marked by the presence of endometrial-like cells outside the uterine cavity, most commonly affecting the ovaries, fallopian tubes, and peritoneum. Despite an estimated prevalence of 10% among women of reproductive age, the condition is often underdiagnosed and underrecognized. Many women endure years of symptoms before receiving an accurate diagnosis, resulting in prolonged physical suffering and significant disruption to daily life. Common symptoms include severe menstrual pain, dyspareunia, chronic pelvic pain, fatigue, and infertility. Due to their cyclical and persistent nature, these symptoms negatively affect women's physical and mental health, social functioning, relationships, and professional life. As there is no definitive cure and symptoms often recur, endometriosis is classified as a chronic illness requiring a comprehensive care approach. This paper explores the multifaceted impact of endometriosis on quality of life and examines key assessment tools such as SF-36, WHOQOL-BREF, and EHP-30. It also includes an overview of current treatment strategies - both pharmacological and surgical - as well as supportive and non-pharmacological approaches. The need for an individualized and multidisciplinary model of care is emphasized to improve outcomes and support the overall well-being of affected women.

My notes (saved in your browser only)

Outcome instruments

EHP-30

Condition tags

endometriosischronic_pelvic_paindyspareuniainfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK